Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 6.40357673 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.63244523 |
3 | L-phenylalanine catabolic process (GO:0006559) | 5.63244523 |
4 | omega-hydroxylase P450 pathway (GO:0097267) | 5.54317723 |
5 | blood coagulation, intrinsic pathway (GO:0007597) | 5.36316067 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.30163545 |
7 | L-phenylalanine metabolic process (GO:0006558) | 5.30163545 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 5.09975365 |
9 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.90832012 |
10 | intestinal cholesterol absorption (GO:0030299) | 4.79423456 |
11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.75397500 |
12 | indole-containing compound catabolic process (GO:0042436) | 4.70168897 |
13 | indolalkylamine catabolic process (GO:0046218) | 4.70168897 |
14 | tryptophan catabolic process (GO:0006569) | 4.70168897 |
15 | negative regulation of sterol transport (GO:0032372) | 4.58618824 |
16 | negative regulation of cholesterol transport (GO:0032375) | 4.58618824 |
17 | kynurenine metabolic process (GO:0070189) | 4.51165512 |
18 | tryptophan metabolic process (GO:0006568) | 4.46432969 |
19 | ethanol metabolic process (GO:0006067) | 4.46342361 |
20 | lysine metabolic process (GO:0006553) | 4.45561093 |
21 | lysine catabolic process (GO:0006554) | 4.45561093 |
22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.41488221 |
23 | oxidative demethylation (GO:0070989) | 4.40137763 |
24 | glyoxylate metabolic process (GO:0046487) | 4.39502204 |
25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.39188039 |
26 | complement activation, alternative pathway (GO:0006957) | 4.37763531 |
27 | bile acid biosynthetic process (GO:0006699) | 4.37320991 |
28 | homocysteine metabolic process (GO:0050667) | 4.37001825 |
29 | low-density lipoprotein particle remodeling (GO:0034374) | 4.34857298 |
30 | valine metabolic process (GO:0006573) | 4.34832498 |
31 | plasma lipoprotein particle assembly (GO:0034377) | 4.33121065 |
32 | fibrinolysis (GO:0042730) | 4.26218534 |
33 | sulfur amino acid catabolic process (GO:0000098) | 4.24767424 |
34 | cysteine metabolic process (GO:0006534) | 4.20696970 |
35 | protein activation cascade (GO:0072376) | 4.19001450 |
36 | negative regulation of complement activation (GO:0045916) | 4.18675732 |
37 | drug metabolic process (GO:0017144) | 4.17232915 |
38 | regulation of plasminogen activation (GO:0010755) | 4.14787618 |
39 | urea metabolic process (GO:0019627) | 4.03314201 |
40 | urea cycle (GO:0000050) | 4.03314201 |
41 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.02217782 |
42 | regulation of protein activation cascade (GO:2000257) | 4.00834942 |
43 | regulation of humoral immune response (GO:0002920) | 4.00278470 |
44 | cellular ketone body metabolic process (GO:0046950) | 4.00234178 |
45 | amino-acid betaine metabolic process (GO:0006577) | 3.98327107 |
46 | plasma lipoprotein particle organization (GO:0071827) | 3.97615729 |
47 | protein carboxylation (GO:0018214) | 3.97499592 |
48 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.97499592 |
49 | fatty acid beta-oxidation (GO:0006635) | 3.97127250 |
50 | regulation of triglyceride catabolic process (GO:0010896) | 3.96626258 |
51 | imidazole-containing compound metabolic process (GO:0052803) | 3.93560712 |
52 | short-chain fatty acid metabolic process (GO:0046459) | 3.88519897 |
53 | 2-oxoglutarate metabolic process (GO:0006103) | 3.85896574 |
54 | regulation of complement activation (GO:0030449) | 3.83312212 |
55 | complement activation, classical pathway (GO:0006958) | 3.82274515 |
56 | biotin metabolic process (GO:0006768) | 3.82245126 |
57 | protein-lipid complex assembly (GO:0065005) | 3.81197269 |
58 | fatty acid oxidation (GO:0019395) | 3.79726702 |
59 | regulation of sequestering of triglyceride (GO:0010889) | 3.79042079 |
60 | * branched-chain amino acid catabolic process (GO:0009083) | 3.76531771 |
61 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.74926760 |
62 | alpha-amino acid catabolic process (GO:1901606) | 3.74323948 |
63 | lipid oxidation (GO:0034440) | 3.74143117 |
64 | bile acid metabolic process (GO:0008206) | 3.74065993 |
65 | high-density lipoprotein particle remodeling (GO:0034375) | 3.71455465 |
66 | protein-lipid complex subunit organization (GO:0071825) | 3.71445497 |
67 | nitrogen cycle metabolic process (GO:0071941) | 3.69434146 |
68 | coenzyme catabolic process (GO:0009109) | 3.69055405 |
69 | triglyceride homeostasis (GO:0070328) | 3.68541683 |
70 | acylglycerol homeostasis (GO:0055090) | 3.68541683 |
71 | fatty acid catabolic process (GO:0009062) | 3.68047861 |
72 | fatty acid transmembrane transport (GO:1902001) | 3.67779899 |
73 | aromatic amino acid family metabolic process (GO:0009072) | 3.63896498 |
74 | complement activation (GO:0006956) | 3.62984016 |
75 | acute-phase response (GO:0006953) | 3.62504025 |
76 | negative regulation of hemostasis (GO:1900047) | 3.62439801 |
77 | negative regulation of blood coagulation (GO:0030195) | 3.62439801 |
78 | acetyl-CoA metabolic process (GO:0006084) | 3.62434489 |
79 | serine family amino acid catabolic process (GO:0009071) | 3.61531277 |
80 | * branched-chain amino acid metabolic process (GO:0009081) | 3.61238447 |
81 | response to mercury ion (GO:0046689) | 3.60258254 |
82 | positive regulation of fatty acid oxidation (GO:0046321) | 3.58757089 |
83 | S-adenosylmethionine metabolic process (GO:0046500) | 3.57817987 |
84 | tyrosine metabolic process (GO:0006570) | 3.57332011 |
85 | * cellular amino acid catabolic process (GO:0009063) | 3.54422740 |
86 | monocarboxylic acid catabolic process (GO:0072329) | 3.53955623 |
87 | cellular modified amino acid catabolic process (GO:0042219) | 3.53067421 |
88 | negative regulation of fibrinolysis (GO:0051918) | 3.51683536 |
89 | regulation of fibrinolysis (GO:0051917) | 3.50106002 |
90 | regulation of apoptotic cell clearance (GO:2000425) | 3.48178310 |
91 | reverse cholesterol transport (GO:0043691) | 3.45898182 |
92 | plasma lipoprotein particle clearance (GO:0034381) | 3.45275337 |
93 | phenylpropanoid metabolic process (GO:0009698) | 3.44452150 |
94 | indolalkylamine metabolic process (GO:0006586) | 3.43912179 |
95 | ketone body metabolic process (GO:1902224) | 3.43901278 |
96 | amine catabolic process (GO:0009310) | 3.40418608 |
97 | cellular biogenic amine catabolic process (GO:0042402) | 3.40418608 |
98 | flavonoid metabolic process (GO:0009812) | 3.39876183 |
99 | phospholipid homeostasis (GO:0055091) | 3.39318833 |
100 | positive regulation of blood coagulation (GO:0030194) | 3.36858621 |
101 | positive regulation of hemostasis (GO:1900048) | 3.36858621 |
102 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.36640138 |
103 | * organic acid catabolic process (GO:0016054) | 3.36516493 |
104 | * carboxylic acid catabolic process (GO:0046395) | 3.36516493 |
105 | glutamate metabolic process (GO:0006536) | 3.36385648 |
106 | glycine metabolic process (GO:0006544) | 3.36033729 |
107 | aspartate family amino acid catabolic process (GO:0009068) | 3.35450297 |
108 | carnitine shuttle (GO:0006853) | 3.33582298 |
109 | ethanol oxidation (GO:0006069) | 3.33074327 |
110 | carnitine metabolic process (GO:0009437) | 3.32597818 |
111 | protein-lipid complex remodeling (GO:0034368) | 3.31765966 |
112 | macromolecular complex remodeling (GO:0034367) | 3.31765966 |
113 | plasma lipoprotein particle remodeling (GO:0034369) | 3.31765966 |
114 | positive regulation of lipid catabolic process (GO:0050996) | 3.30479966 |
115 | negative regulation of coagulation (GO:0050819) | 3.26752539 |
116 | cellular glucuronidation (GO:0052695) | 3.24886417 |
117 | lipoprotein metabolic process (GO:0042157) | 3.23765225 |
118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.21390360 |
119 | benzene-containing compound metabolic process (GO:0042537) | 3.18419988 |
120 | negative regulation of lipase activity (GO:0060192) | 3.16817397 |
121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.16604475 |
122 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.16604475 |
123 | negative regulation of humoral immune response (GO:0002921) | 3.16586996 |
124 | sodium-independent organic anion transport (GO:0043252) | 3.16517826 |
125 | negative regulation of wound healing (GO:0061045) | 3.15592967 |
126 | opsonization (GO:0008228) | 3.15142897 |
127 | linoleic acid metabolic process (GO:0043651) | 3.14662536 |
128 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.12047746 |
129 | drug transmembrane transport (GO:0006855) | 3.05933409 |
130 | regulation of cholesterol esterification (GO:0010872) | 3.03179752 |
131 | bile acid and bile salt transport (GO:0015721) | 3.01671541 |
132 | phospholipid efflux (GO:0033700) | 3.00728763 |
133 | cytolysis (GO:0019835) | 2.96817707 |
134 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.96378635 |
135 | epoxygenase P450 pathway (GO:0019373) | 2.91005649 |
136 | regulation of fatty acid oxidation (GO:0046320) | 2.90534942 |
137 | glucuronate metabolic process (GO:0019585) | 2.90148156 |
138 | uronic acid metabolic process (GO:0006063) | 2.90148156 |
139 | drug catabolic process (GO:0042737) | 2.88164707 |
140 | cholesterol efflux (GO:0033344) | 2.86831007 |
141 | tricarboxylic acid metabolic process (GO:0072350) | 2.86175155 |
142 | acylglycerol catabolic process (GO:0046464) | 2.82502317 |
143 | neutral lipid catabolic process (GO:0046461) | 2.82502317 |
144 | succinate metabolic process (GO:0006105) | 2.82257737 |
145 | negative regulation of protein activation cascade (GO:2000258) | 2.79254345 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.80132454 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.94254132 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.69087259 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.16532987 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.10253170 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.98617385 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.43554463 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.01583023 |
9 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.35717937 |
10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17982502 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14375997 |
12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96923681 |
13 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.92752302 |
14 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.80345570 |
15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71104268 |
16 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.62436198 |
17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62404096 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58429103 |
19 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56860261 |
20 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54328143 |
21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50964036 |
22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48914630 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48192526 |
24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47198581 |
25 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46598007 |
26 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.46365834 |
27 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.46365834 |
28 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40403488 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39618706 |
30 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38642125 |
31 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38240200 |
32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38058950 |
33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37357351 |
34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32701008 |
35 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.31088809 |
36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.29591479 |
37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28534627 |
38 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28310612 |
39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26673138 |
40 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25099098 |
41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24834683 |
42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22434048 |
43 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21822691 |
44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21783151 |
45 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21047568 |
46 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.20872030 |
47 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.20451661 |
48 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16070953 |
49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14644824 |
50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13457748 |
51 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13168173 |
52 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13150973 |
53 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.12505075 |
54 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.12429659 |
55 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11443943 |
56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.11144001 |
57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10145635 |
58 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08273487 |
59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.06883718 |
60 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.06759188 |
61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06293270 |
62 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.05518598 |
63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05324627 |
64 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05080670 |
65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04741691 |
66 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04716508 |
67 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02244593 |
68 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.02231566 |
69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02098389 |
70 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01693889 |
71 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00778178 |
72 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00299893 |
73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99955117 |
74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98677678 |
75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98642369 |
76 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.98633710 |
77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98190661 |
78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97800910 |
79 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97787253 |
80 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97764731 |
81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97680340 |
82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97612408 |
83 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97201979 |
84 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97074170 |
85 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.96898954 |
86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96656173 |
87 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96650269 |
88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96617104 |
89 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96590056 |
90 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96341428 |
91 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.95975686 |
92 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94895229 |
93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94528084 |
94 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.93719441 |
95 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.92257339 |
96 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91647041 |
97 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91306699 |
98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90432875 |
99 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89965041 |
100 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89913893 |
101 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89547442 |
102 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.89172959 |
103 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.89172959 |
104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88756797 |
105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87850705 |
106 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87471600 |
107 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.86747821 |
108 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86542979 |
109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86441672 |
110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84827875 |
111 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.84663322 |
112 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.84291716 |
113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84218642 |
114 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.83938593 |
115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.81728554 |
116 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81458632 |
117 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.80224394 |
118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79968849 |
119 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79858350 |
120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79858350 |
121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79712347 |
122 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79137061 |
123 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78722986 |
124 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77970029 |
125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77572476 |
126 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77534538 |
127 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77020237 |
128 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77020237 |
129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76273642 |
130 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.76044932 |
131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75584880 |
132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75456746 |
133 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.75329169 |
134 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74309671 |
135 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.73644909 |
136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73625548 |
137 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.72487714 |
138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72404226 |
139 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72397050 |
140 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.72029457 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.55313265 |
2 | MP0005360_urolithiasis | 5.91604492 |
3 | MP0005365_abnormal_bile_salt | 5.42143658 |
4 | MP0005085_abnormal_gallbladder_physiolo | 5.11601998 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.89385674 |
6 | MP0003252_abnormal_bile_duct | 3.43050229 |
7 | MP0010329_abnormal_lipoprotein_level | 3.22677009 |
8 | MP0003195_calcinosis | 2.95100559 |
9 | MP0005083_abnormal_biliary_tract | 2.67448034 |
10 | MP0005670_abnormal_white_adipose | 2.64087516 |
11 | MP0005332_abnormal_amino_acid | 2.59536361 |
12 | MP0004130_abnormal_muscle_cell | 2.51361414 |
13 | MP0002837_dystrophic_cardiac_calcinosis | 2.49793287 |
14 | MP0001666_abnormal_nutrient_absorption | 2.48553805 |
15 | MP0003806_abnormal_nucleotide_metabolis | 2.39907926 |
16 | MP0002118_abnormal_lipid_homeostasis | 2.13786383 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.00988985 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.75213751 |
19 | MP0003868_abnormal_feces_composition | 1.75133942 |
20 | MP0000609_abnormal_liver_physiology | 1.68900974 |
21 | MP0005666_abnormal_adipose_tissue | 1.66741843 |
22 | MP0002876_abnormal_thyroid_physiology | 1.65561995 |
23 | MP0003191_abnormal_cellular_cholesterol | 1.64748503 |
24 | MP0008438_abnormal_cutaneous_collagen | 1.64454021 |
25 | MP0004145_abnormal_muscle_electrophysio | 1.60747562 |
26 | MP0005408_hypopigmentation | 1.58311619 |
27 | MP0003122_maternal_imprinting | 1.55288539 |
28 | MP0005319_abnormal_enzyme/_coenzyme | 1.54593292 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44748270 |
30 | MP0009840_abnormal_foam_cell | 1.43219989 |
31 | MP0009780_abnormal_chondrocyte_physiolo | 1.36168612 |
32 | MP0001764_abnormal_homeostasis | 1.34966880 |
33 | MP0002971_abnormal_brown_adipose | 1.34294327 |
34 | MP0009643_abnormal_urine_homeostasis | 1.32667567 |
35 | MP0003879_abnormal_hair_cell | 1.29073054 |
36 | MP0004043_abnormal_pH_regulation | 1.27182197 |
37 | MP0005535_abnormal_body_temperature | 1.26609662 |
38 | MP0005334_abnormal_fat_pad | 1.25921631 |
39 | MP0002078_abnormal_glucose_homeostasis | 1.23343666 |
40 | MP0005647_abnormal_sex_gland | 1.19146770 |
41 | MP0005375_adipose_tissue_phenotype | 1.17051322 |
42 | MP0009697_abnormal_copulation | 1.15315726 |
43 | MP0004185_abnormal_adipocyte_glucose | 1.14477913 |
44 | MP0005220_abnormal_exocrine_pancreas | 1.10630254 |
45 | MP0005275_abnormal_skin_tensile | 1.10584671 |
46 | MP0002254_reproductive_system_inflammat | 1.09776468 |
47 | MP0003011_delayed_dark_adaptation | 1.05725658 |
48 | MP0005551_abnormal_eye_electrophysiolog | 1.05230067 |
49 | MP0005451_abnormal_body_composition | 1.01997793 |
50 | MP0003186_abnormal_redox_activity | 1.01104141 |
51 | MP0003646_muscle_fatigue | 0.99102727 |
52 | MP0001661_extended_life_span | 0.98195090 |
53 | MP0000013_abnormal_adipose_tissue | 0.97838176 |
54 | MP0003705_abnormal_hypodermis_morpholog | 0.97699123 |
55 | MP0005636_abnormal_mineral_homeostasis | 0.95635412 |
56 | MP0003959_abnormal_lean_body | 0.94921066 |
57 | MP0001756_abnormal_urination | 0.94353436 |
58 | MP0005084_abnormal_gallbladder_morpholo | 0.94092605 |
59 | MP0009764_decreased_sensitivity_to | 0.93948012 |
60 | MP0010368_abnormal_lymphatic_system | 0.90867355 |
61 | MP0009384_cardiac_valve_regurgitation | 0.90605894 |
62 | MP0005448_abnormal_energy_balance | 0.90358663 |
63 | MP0000751_myopathy | 0.89510633 |
64 | MP0006036_abnormal_mitochondrial_physio | 0.88093396 |
65 | MP0001501_abnormal_sleep_pattern | 0.86132317 |
66 | MP0000003_abnormal_adipose_tissue | 0.85374828 |
67 | MP0004147_increased_porphyrin_level | 0.84919549 |
68 | MP0004084_abnormal_cardiac_muscle | 0.84698336 |
69 | MP0005266_abnormal_metabolism | 0.83893990 |
70 | MP0003690_abnormal_glial_cell | 0.82698671 |
71 | MP0000230_abnormal_systemic_arterial | 0.81127068 |
72 | MP0005167_abnormal_blood-brain_barrier | 0.80649233 |
73 | MP0002269_muscular_atrophy | 0.80507535 |
74 | MP0003950_abnormal_plasma_membrane | 0.78618546 |
75 | MP0002106_abnormal_muscle_physiology | 0.78377810 |
76 | MP0009115_abnormal_fat_cell | 0.78143409 |
77 | MP0009642_abnormal_blood_homeostasis | 0.76754621 |
78 | MP0003633_abnormal_nervous_system | 0.76015048 |
79 | MP0004215_abnormal_myocardial_fiber | 0.75736714 |
80 | MP0004036_abnormal_muscle_relaxation | 0.75480881 |
81 | MP0003953_abnormal_hormone_level | 0.74162066 |
82 | MP0001984_abnormal_olfaction | 0.73689386 |
83 | MP0006054_spinal_hemorrhage | 0.73435445 |
84 | MP0009763_increased_sensitivity_to | 0.73211417 |
85 | MP0005187_abnormal_penis_morphology | 0.72743203 |
86 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72039654 |
87 | MP0005377_hearing/vestibular/ear_phenot | 0.71985709 |
88 | MP0003878_abnormal_ear_physiology | 0.71985709 |
89 | MP0005620_abnormal_muscle_contractility | 0.71037399 |
90 | MP0002168_other_aberrant_phenotype | 0.70684350 |
91 | MP0001881_abnormal_mammary_gland | 0.70391309 |
92 | MP0001915_intracranial_hemorrhage | 0.69464158 |
93 | MP0000598_abnormal_liver_morphology | 0.68890459 |
94 | MP0005395_other_phenotype | 0.68295563 |
95 | MP0005330_cardiomyopathy | 0.67447093 |
96 | MP0005369_muscle_phenotype | 0.66382958 |
97 | MP0003656_abnormal_erythrocyte_physiolo | 0.66378705 |
98 | MP0008872_abnormal_physiological_respon | 0.66254485 |
99 | MP0000749_muscle_degeneration | 0.63800878 |
100 | MP0005386_behavior/neurological_phenoty | 0.63078380 |
101 | MP0004924_abnormal_behavior | 0.63078380 |
102 | MP0008775_abnormal_heart_ventricle | 0.61951496 |
103 | MP0001765_abnormal_ion_homeostasis | 0.61709184 |
104 | MP0006138_congestive_heart_failure | 0.61454079 |
105 | MP0002108_abnormal_muscle_morphology | 0.60713474 |
106 | MP0002972_abnormal_cardiac_muscle | 0.60502289 |
107 | MP0001944_abnormal_pancreas_morphology | 0.60202909 |
108 | MP0002060_abnormal_skin_morphology | 0.60025252 |
109 | MP0002132_abnormal_respiratory_system | 0.59629562 |
110 | MP0002909_abnormal_adrenal_gland | 0.59052068 |
111 | MP0005248_abnormal_Harderian_gland | 0.58490556 |
112 | MP0000538_abnormal_urinary_bladder | 0.57869647 |
113 | MP0002928_abnormal_bile_duct | 0.57675584 |
114 | MP0005503_abnormal_tendon_morphology | 0.57406475 |
115 | MP0005376_homeostasis/metabolism_phenot | 0.57025065 |
116 | MP0002295_abnormal_pulmonary_circulatio | 0.56636045 |
117 | MP0003123_paternal_imprinting | 0.56373827 |
118 | MP0005646_abnormal_pituitary_gland | 0.55933350 |
119 | MP0004272_abnormal_basement_membrane | 0.55020052 |
120 | MP0003631_nervous_system_phenotype | 0.54994456 |
121 | MP0004085_abnormal_heartbeat | 0.54092133 |
122 | MP0000639_abnormal_adrenal_gland | 0.53943756 |
123 | MP0002160_abnormal_reproductive_system | 0.52692831 |
124 | MP0004782_abnormal_surfactant_physiolog | 0.52525799 |
125 | MP0003724_increased_susceptibility_to | 0.52394503 |
126 | MP0001177_atelectasis | 0.52158064 |
127 | MP0010386_abnormal_urinary_bladder | 0.52149666 |
128 | MP0005385_cardiovascular_system_phenoty | 0.52106928 |
129 | MP0001544_abnormal_cardiovascular_syste | 0.52106928 |
130 | MP0004484_altered_response_of | 0.52067001 |
131 | MP0004087_abnormal_muscle_fiber | 0.50554664 |
132 | MP0003890_abnormal_embryonic-extraembry | 0.50447411 |
133 | MP0000604_amyloidosis | 0.50330463 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 5.46215829 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.17085873 |
3 | Deep venous thrombosis (HP:0002625) | 5.06600916 |
4 | Xanthomatosis (HP:0000991) | 4.84478536 |
5 | Ketosis (HP:0001946) | 4.73662926 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 4.70934654 |
7 | Complement deficiency (HP:0004431) | 4.70439403 |
8 | Hypoglycemic coma (HP:0001325) | 4.68584168 |
9 | Hyperglycinuria (HP:0003108) | 4.59448226 |
10 | Ketoacidosis (HP:0001993) | 4.43054798 |
11 | Hyperlipoproteinemia (HP:0010980) | 4.24276698 |
12 | Abnormality of glycine metabolism (HP:0010895) | 4.22871663 |
13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.22871663 |
14 | Hyperammonemia (HP:0001987) | 4.21947608 |
15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.20850183 |
16 | Hyperglycinemia (HP:0002154) | 4.14688046 |
17 | Hypoalphalipoproteinemia (HP:0003233) | 3.97296081 |
18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.93348576 |
19 | Epidermoid cyst (HP:0200040) | 3.85209383 |
20 | Hypobetalipoproteinemia (HP:0003563) | 3.83165151 |
21 | Hypolipoproteinemia (HP:0010981) | 3.69116111 |
22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.64290904 |
23 | Abnormality of the intrinsic pathway (HP:0010989) | 3.49847632 |
24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.49374548 |
25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.42745719 |
26 | Joint hemorrhage (HP:0005261) | 3.40014468 |
27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38505381 |
28 | Abnormality of complement system (HP:0005339) | 3.24836378 |
29 | Fat malabsorption (HP:0002630) | 3.21148088 |
30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.12354877 |
31 | Hypoglycemic seizures (HP:0002173) | 3.12140999 |
32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.11663927 |
33 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.05522064 |
34 | Abnormality of purine metabolism (HP:0004352) | 3.01860677 |
35 | Dicarboxylic aciduria (HP:0003215) | 2.99237724 |
36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.99237724 |
37 | Nephritis (HP:0000123) | 2.94013740 |
38 | Skin nodule (HP:0200036) | 2.93491266 |
39 | Gout (HP:0001997) | 2.88752369 |
40 | Generalized aminoaciduria (HP:0002909) | 2.85807656 |
41 | Abnormality of methionine metabolism (HP:0010901) | 2.83848800 |
42 | Metabolic acidosis (HP:0001942) | 2.82980678 |
43 | Abnormality of serum amino acid levels (HP:0003112) | 2.82510902 |
44 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.77952931 |
45 | Myocardial infarction (HP:0001658) | 2.73833540 |
46 | Fair hair (HP:0002286) | 2.71645269 |
47 | Delayed CNS myelination (HP:0002188) | 2.70776438 |
48 | Renal cortical cysts (HP:0000803) | 2.69202358 |
49 | Myoglobinuria (HP:0002913) | 2.68459000 |
50 | Hypercholesterolemia (HP:0003124) | 2.68072183 |
51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.61074878 |
52 | Enlarged kidneys (HP:0000105) | 2.60789962 |
53 | Menorrhagia (HP:0000132) | 2.57334776 |
54 | Hyperglycemia (HP:0003074) | 2.54471619 |
55 | Acanthocytosis (HP:0001927) | 2.53477313 |
56 | Proximal tubulopathy (HP:0000114) | 2.52816337 |
57 | Osteomalacia (HP:0002749) | 2.50442407 |
58 | Cerebral edema (HP:0002181) | 2.47531872 |
59 | Hydroxyprolinuria (HP:0003080) | 2.46127585 |
60 | Abnormality of proline metabolism (HP:0010907) | 2.46127585 |
61 | Gingival bleeding (HP:0000225) | 2.44010542 |
62 | Steatorrhea (HP:0002570) | 2.41059461 |
63 | Muscle fiber inclusion bodies (HP:0100299) | 2.40027945 |
64 | Symptomatic seizures (HP:0011145) | 2.39305502 |
65 | Hepatocellular carcinoma (HP:0001402) | 2.38643667 |
66 | Hyperbilirubinemia (HP:0002904) | 2.37959782 |
67 | Oligomenorrhea (HP:0000876) | 2.37803514 |
68 | * Lethargy (HP:0001254) | 2.37201030 |
69 | Systemic lupus erythematosus (HP:0002725) | 2.37074412 |
70 | Rickets (HP:0002748) | 2.35349560 |
71 | Nemaline bodies (HP:0003798) | 2.32297303 |
72 | Increased purine levels (HP:0004368) | 2.27850987 |
73 | Hyperuricemia (HP:0002149) | 2.27850987 |
74 | Pancreatitis (HP:0001733) | 2.27603056 |
75 | Hypophosphatemic rickets (HP:0004912) | 2.24950206 |
76 | Exercise-induced myalgia (HP:0003738) | 2.23811404 |
77 | Vascular calcification (HP:0004934) | 2.23616654 |
78 | Thrombophlebitis (HP:0004418) | 2.21525316 |
79 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.21366370 |
80 | Vomiting (HP:0002013) | 2.21354008 |
81 | Cardiovascular calcification (HP:0011915) | 2.19014736 |
82 | Arthropathy (HP:0003040) | 2.17016775 |
83 | Abnormality of the nasal septum (HP:0000419) | 2.16459084 |
84 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.15798770 |
85 | Potter facies (HP:0002009) | 2.10954281 |
86 | Facial shape deformation (HP:0011334) | 2.10954281 |
87 | Joint swelling (HP:0001386) | 2.10111554 |
88 | Sensorimotor neuropathy (HP:0007141) | 2.08138327 |
89 | Mitral stenosis (HP:0001718) | 2.05893901 |
90 | Abnormal gallbladder morphology (HP:0012437) | 2.04418631 |
91 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.03442563 |
92 | Right ventricular cardiomyopathy (HP:0011663) | 2.02591276 |
93 | Poikilocytosis (HP:0004447) | 2.01757778 |
94 | Calf muscle hypertrophy (HP:0008981) | 2.00976273 |
95 | Generalized hypopigmentation of hair (HP:0011358) | 2.00242209 |
96 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.99552190 |
97 | Cholelithiasis (HP:0001081) | 1.98150275 |
98 | Pigmentary retinal degeneration (HP:0001146) | 1.97780161 |
99 | Abnormal tarsal ossification (HP:0008369) | 1.96609269 |
100 | Blue irides (HP:0000635) | 1.94826827 |
101 | Neonatal onset (HP:0003623) | 1.91292741 |
102 | Hypochromic microcytic anemia (HP:0004840) | 1.90388771 |
103 | Nausea (HP:0002018) | 1.89597617 |
104 | Late onset (HP:0003584) | 1.88449872 |
105 | Increased circulating renin level (HP:0000848) | 1.86031904 |
106 | Hypertriglyceridemia (HP:0002155) | 1.82595253 |
107 | Abnormality of alanine metabolism (HP:0010916) | 1.82032968 |
108 | Hyperalaninemia (HP:0003348) | 1.82032968 |
109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82032968 |
110 | Abnormality of vitamin metabolism (HP:0100508) | 1.81343215 |
111 | Protuberant abdomen (HP:0001538) | 1.81228223 |
112 | Alkalosis (HP:0001948) | 1.79506837 |
113 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.79503279 |
114 | Turricephaly (HP:0000262) | 1.79199792 |
115 | Spontaneous abortion (HP:0005268) | 1.79045735 |
116 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75918524 |
117 | Pulmonary embolism (HP:0002204) | 1.75906546 |
118 | Increased serum pyruvate (HP:0003542) | 1.74214804 |
119 | Abnormality of the renal cortex (HP:0011035) | 1.73150876 |
120 | Esophageal varix (HP:0002040) | 1.70702535 |
121 | Hemorrhage of the eye (HP:0011885) | 1.68974060 |
122 | Irritability (HP:0000737) | 1.68930994 |
123 | Abnormality of urine glucose concentration (HP:0011016) | 1.68680675 |
124 | Glycosuria (HP:0003076) | 1.68680675 |
125 | Brushfield spots (HP:0001088) | 1.67609428 |
126 | Glomerulonephritis (HP:0000099) | 1.67370117 |
127 | Abnormality of the gallbladder (HP:0005264) | 1.66890170 |
128 | Hypokalemia (HP:0002900) | 1.66623634 |
129 | Abnormality of potassium homeostasis (HP:0011042) | 1.66146030 |
130 | Respiratory distress (HP:0002098) | 1.65717779 |
131 | Tachypnea (HP:0002789) | 1.64323860 |
132 | Hyperphosphaturia (HP:0003109) | 1.64241851 |
133 | Purpura (HP:0000979) | 1.63753335 |
134 | Amyloidosis (HP:0011034) | 1.62440509 |
135 | Exercise-induced muscle cramps (HP:0003710) | 1.62142397 |
136 | Rhabdomyolysis (HP:0003201) | 1.62062224 |
137 | Back pain (HP:0003418) | 1.62041297 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.79380465 |
2 | INSRR | 4.06533179 |
3 | MAP3K13 | 4.06455981 |
4 | SIK1 | 3.69823293 |
5 | STK39 | 2.47310758 |
6 | FRK | 2.45602861 |
7 | ERN1 | 2.45525469 |
8 | CAMK1D | 2.14515499 |
9 | FGFR4 | 2.13071782 |
10 | PDK3 | 1.99969488 |
11 | PDK4 | 1.99969488 |
12 | LMTK2 | 1.82243252 |
13 | TAOK3 | 1.82067399 |
14 | LATS1 | 1.82058211 |
15 | PIK3CG | 1.81035596 |
16 | TRIB3 | 1.62763782 |
17 | PIK3CA | 1.62381530 |
18 | CAMK1G | 1.60400329 |
19 | PHKG2 | 1.56375103 |
20 | PHKG1 | 1.56375103 |
21 | FGFR2 | 1.52694453 |
22 | MYLK | 1.49129400 |
23 | PRKAA2 | 1.46739684 |
24 | EIF2AK3 | 1.46472118 |
25 | ERBB4 | 1.45455256 |
26 | MAP4K2 | 1.44933223 |
27 | PDK2 | 1.44898811 |
28 | TTN | 1.44792451 |
29 | OBSCN | 1.42214759 |
30 | ACVR1B | 1.41295733 |
31 | MAP2K4 | 1.36585053 |
32 | STK38L | 1.34615826 |
33 | MST1R | 1.32869011 |
34 | WNK4 | 1.32405989 |
35 | EPHA3 | 1.29074053 |
36 | SGK2 | 1.22193072 |
37 | PINK1 | 1.21571891 |
38 | PDGFRA | 1.20645514 |
39 | JAK1 | 1.19073945 |
40 | TIE1 | 1.18223064 |
41 | SGK3 | 1.14970218 |
42 | NEK9 | 1.11435852 |
43 | NLK | 1.11129732 |
44 | WNK3 | 1.08598587 |
45 | WNK1 | 1.07947699 |
46 | TRPM7 | 1.07919685 |
47 | AKT3 | 1.07254317 |
48 | BMPR1B | 1.07241896 |
49 | GRK1 | 1.06193342 |
50 | PRKAA1 | 1.05496903 |
51 | FLT3 | 1.04628235 |
52 | FGFR1 | 1.04360788 |
53 | MAP3K7 | 1.03787424 |
54 | MAP3K9 | 0.98054934 |
55 | PTK6 | 0.97898463 |
56 | FER | 0.97079506 |
57 | EEF2K | 0.96390021 |
58 | SGK223 | 0.92735801 |
59 | SGK494 | 0.92735801 |
60 | TGFBR2 | 0.91305275 |
61 | IRAK3 | 0.90937017 |
62 | PKN2 | 0.90857418 |
63 | TLK1 | 0.90133792 |
64 | CDK12 | 0.87963105 |
65 | CAMKK2 | 0.87428975 |
66 | MAPK11 | 0.85710431 |
67 | BMPR2 | 0.82004161 |
68 | MAP2K6 | 0.81965347 |
69 | ICK | 0.80946934 |
70 | DAPK2 | 0.80599534 |
71 | FGFR3 | 0.79902230 |
72 | CASK | 0.79571212 |
73 | JAK2 | 0.79299717 |
74 | PAK3 | 0.75805280 |
75 | MAPK12 | 0.73953312 |
76 | BRSK2 | 0.72372598 |
77 | RIPK1 | 0.71600434 |
78 | EPHA4 | 0.70484798 |
79 | TXK | 0.70115088 |
80 | NUAK1 | 0.66978375 |
81 | ERBB3 | 0.66557724 |
82 | PKN1 | 0.66132016 |
83 | MET | 0.65951228 |
84 | PRKCE | 0.65848104 |
85 | MAP3K2 | 0.65748872 |
86 | PRKACG | 0.64814349 |
87 | PRKCH | 0.64685846 |
88 | KSR2 | 0.64251665 |
89 | GRK7 | 0.64132403 |
90 | TNK2 | 0.59371965 |
91 | MAPK15 | 0.58619715 |
92 | MAPK13 | 0.58496303 |
93 | OXSR1 | 0.58155023 |
94 | TAOK2 | 0.55024342 |
95 | EIF2AK2 | 0.54944960 |
96 | PRKCZ | 0.54729346 |
97 | IGF1R | 0.53744150 |
98 | BRD4 | 0.52350798 |
99 | ROCK1 | 0.52262169 |
100 | PRKG1 | 0.51246600 |
101 | RET | 0.50255795 |
102 | PRKCG | 0.50251934 |
103 | IRAK1 | 0.50188307 |
104 | PDPK1 | 0.49830477 |
105 | CAMK4 | 0.49453891 |
106 | RPS6KB1 | 0.48988467 |
107 | MAP2K1 | 0.48661157 |
108 | DMPK | 0.48386204 |
109 | DDR2 | 0.48029070 |
110 | PRKD1 | 0.46968840 |
111 | GSK3A | 0.46795494 |
112 | MKNK2 | 0.46773429 |
113 | CAMK2G | 0.46730598 |
114 | CSNK1E | 0.46303558 |
115 | MAP3K14 | 0.46162536 |
116 | PDGFRB | 0.44913537 |
117 | MAP2K7 | 0.44764071 |
118 | MAPK7 | 0.44400771 |
119 | STK38 | 0.43449715 |
120 | RPS6KA3 | 0.43126792 |
121 | MAP3K4 | 0.42389415 |
122 | SGK1 | 0.41899946 |
123 | NTRK3 | 0.41100468 |
124 | MAP3K3 | 0.39121880 |
125 | ERBB2 | 0.38480657 |
126 | ADRBK2 | 0.38152835 |
127 | PRPF4B | 0.38123712 |
128 | EPHB2 | 0.37913774 |
129 | PRKACA | 0.37792780 |
130 | PRKACB | 0.37010817 |
131 | SIK3 | 0.36605243 |
132 | IRAK2 | 0.36594870 |
133 | TYK2 | 0.36479280 |
134 | MUSK | 0.36175828 |
135 | CDC42BPA | 0.35832064 |
136 | MAPKAPK3 | 0.35175367 |
137 | PDK1 | 0.33141011 |
138 | CSNK1D | 0.31860760 |
139 | CHUK | 0.31110577 |
140 | PRKCB | 0.26014543 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.56403984 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.14355324 |
3 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.02454629 |
4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.00389056 |
5 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.86100173 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75324406 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63329221 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54203142 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.50662697 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.41978871 |
11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40626226 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.27321156 |
13 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.26357567 |
14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.22946377 |
15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.14504881 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.07417910 |
17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.96116648 |
18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87649803 |
19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82852964 |
20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80442353 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73300923 |
22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.72424391 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70825029 |
24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69416427 |
25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.60963567 |
26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.51595167 |
27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49761126 |
28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.47789795 |
29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46561134 |
30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.45572141 |
31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.44765172 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.43126556 |
33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40504978 |
34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36716249 |
35 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.35878546 |
36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35839729 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28879217 |
38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27887342 |
39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26434125 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.25948810 |
41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25909688 |
42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24663103 |
43 | ABC transporters_Homo sapiens_hsa02010 | 1.23784403 |
44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.21697330 |
45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16243860 |
46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.15759604 |
47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12163548 |
48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10762245 |
49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.00510472 |
50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97258422 |
51 | Lysine degradation_Homo sapiens_hsa00310 | 0.94179621 |
52 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85694168 |
53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84761114 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83931046 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83106229 |
56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82280761 |
57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.73202822 |
58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69508515 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69435769 |
60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69274741 |
61 | Insulin resistance_Homo sapiens_hsa04931 | 0.65718206 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61831192 |
63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61130336 |
64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.54605226 |
65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48497610 |
66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48225484 |
67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43584209 |
68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.41738832 |
69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40913479 |
70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39200026 |
71 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.38573704 |
72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37184866 |
73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.35347272 |
74 | Mineral absorption_Homo sapiens_hsa04978 | 0.33596051 |
75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.31870180 |
76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28780390 |
77 | Prion diseases_Homo sapiens_hsa05020 | 0.27624316 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27348870 |
79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27227197 |
80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23850648 |
81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22994460 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.22936580 |
83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22388747 |
84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21962979 |
85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19967982 |
86 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17858649 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.17839700 |
88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.17298732 |
89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13361514 |
90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13300886 |
91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.13112966 |
92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12130876 |
93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10684978 |
94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.09646819 |
95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.09269599 |
96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09046702 |
97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.09009577 |
98 | Insulin secretion_Homo sapiens_hsa04911 | 0.08772928 |
99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08530275 |
100 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.07707435 |
101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.07618796 |
102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.05666311 |
103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05098364 |
104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03912392 |
105 | Renin secretion_Homo sapiens_hsa04924 | 0.03862987 |
106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.03616206 |
107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.03402718 |
108 | Phototransduction_Homo sapiens_hsa04744 | 0.02402648 |
109 | Amoebiasis_Homo sapiens_hsa05146 | 0.00133071 |
110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | -0.0736757 |
111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | -0.0581788 |
112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0358588 |
113 | Calcium signaling pathway_Homo sapiens_hsa04020 | -0.0299633 |
114 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0242740 |
115 | Pertussis_Homo sapiens_hsa05133 | -0.0082390 |
116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0031808 |